SDF-1α reduces fibronectin expression in rat mesangial cells induced by TGF-β1 and high glucose through PI3K/Akt pathway-Reference-Cited by-同舟云学术

SDF-1α reduces fibronectin expression in rat mesangial cells induced by TGF-β1 and high glucose through PI3K/Akt pathway

Published:2013-07 Issue:12 Volume:319 Page:1796-1803
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Zhang Dan,Shao Shiying,Shuai Hongxia,Ding Yunchuan,Shi Wei,Wang Daowen,Yu Xuefeng

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cell Biology

Reference42 articles.

1. Transforming growth factor beta in tissue fibrosis;Border;New Engl. J. Med.,1994

2. Pathogenesis, prevention, and treatment of diabetic nephropathy;Cooper;Lancet,1998

3. IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy;Lupia;Diabetes,1999

4. Extracellular signal-regulated kinase mediates stimulation of TGF-beta1 and matrix by high glucose in mesangial cells;Isono;J. Am. Soc. Nephrol.,2000

5. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse;Hong;Am. J. Pathol.,2001

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Legumain: a potential biomarker for atherosclerosis;Journal of Pharmacy and Pharmacology;2023-08-16

2. Luteolin improves nephropathy in hyperglycemic rats through anti-oxidant, anti-inflammatory, and anti-apoptotic mechanisms;Journal of Functional Foods;2023-03

3. Transplantation of Human Amniotic Mesenchymal Stem Cells Up-Regulates Angiogenic Factor Expression to Attenuate Diabetic Kidney Disease in Rats;Diabetes, Metabolic Syndrome and Obesity;2023-02

4. Saxagliptin alleviates erectile dysfunction through increasing stromal cell‐derived factor‐1 in diabetes mellitus;Andrology;2022-09-26

5. Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis;Advanced Drug Delivery Reviews;2021-05